# Asymptomatic TB With Innovative Modified Short-course Regimens

> **NCT06153069** · PHASE4 · RECRUITING · sponsor: **Huashan Hospital** · enrollment: 426 (estimated)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Four-month regimen
- **DRUG:** Three-month regimen
- **DRUG:** Standard regimen

## Key facts

- **NCT ID:** NCT06153069
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-21
- **Primary completion:** 2027-11
- **Final completion:** 2028-11
- **Target enrollment:** 426 (ESTIMATED)
- **Last updated:** 2026-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06153069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06153069, "Asymptomatic TB With Innovative Modified Short-course Regimens". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06153069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*